This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ fluvoxamine maleate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Treatment of Depression: Fluvoxamine maleate is primarily used for the treatment of depression, including major depressive disorder (MDD). It helps alleviate symptoms of depression by increasing the levels of serotonin, a neurotransmitter associated with mood regulation, in the brain.

  2. Management of Obsessive-Compulsive Disorder (OCD): Fluvoxamine is also FDA-approved for the treatment of obsessive-compulsive disorder (OCD). It can help reduce the frequency and severity of obsessive thoughts and compulsive behaviors characteristic of OCD.

  3. Social Anxiety Disorder (Social Phobia): Fluvoxamine may be prescribed off-label for the treatment of social anxiety disorder (social phobia). It can help alleviate symptoms of anxiety in social situations and improve overall functioning.

  4. Generalized Anxiety Disorder (GAD): Some healthcare providers may prescribe fluvoxamine off-label for the treatment of generalized anxiety disorder (GAD). It may help reduce excessive worrying, tension, and other symptoms associated with GAD.

  5. Panic Disorder: Fluvoxamine may be used off-label for the treatment of panic disorder, particularly in cases where other medications have been ineffective or poorly tolerated. It can help reduce the frequency and severity of panic attacks.

  6. Post-Traumatic Stress Disorder (PTSD): Fluvoxamine may be prescribed off-label for the treatment of post-traumatic stress disorder (PTSD). It can help alleviate symptoms such as intrusive thoughts, nightmares, hypervigilance, and avoidance behaviors.

  7. Premenstrual Dysphoric Disorder (PMDD): Fluvoxamine may be used off-label for the treatment of premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome (PMS) characterized by significant mood disturbances. It can help alleviate symptoms such as irritability, mood swings, and tension.

  8. Other Conditions: Fluvoxamine may also have potential efficacy in other psychiatric conditions, such as eating disorders (e.g., binge-eating disorder), body dysmorphic disorder, and certain impulse control disorders.

  9. Side Effects: Common side effects of fluvoxamine may include nausea, vomiting, diarrhea, dizziness, drowsiness, headache, insomnia, and sexual dysfunction. It may also increase the risk of suicidal thoughts and behaviors, particularly in young adults and adolescents.

  10. Drug Interactions: Fluvoxamine may interact with other medications, including other antidepressants, certain antibiotics, anticoagulants, antiplatelet drugs, and medications metabolized by the cytochrome P450 system. It is important to inform healthcare providers about all medications, supplements, and herbal products being taken to avoid potential interactions.

  11. Monitoring: Patients taking fluvoxamine may require regular monitoring of symptoms, especially during the initial weeks of treatment and after dosage adjustments. Close monitoring is necessary to assess for treatment response, side effects, and potential emergence of suicidal thoughts or behaviors.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of fluvoxamine maleate,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium bifidum Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Blautia wexlerae Reduces
species Christensenella minuta Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Veillonella atypica Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by fluvoxamine maleate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Clostridioides genus Decreases
0 1 Veillonella genus Decreases
1 0 Akkermansia genus Decreases
0 1 Eggerthella genus Decreases
0 1 Bifidobacterium genus Decreases
0 2 Escherichia genus Decreases
0 1 Agathobacter genus Decreases
0 1 Collinsella genus Decreases
0 1 Dorea genus Decreases
0 1 Odoribacter genus Decreases
0 1 Lachnospira genus Decreases
0 1 Segatella genus Decreases
0 1 Candida genus Decreases
0 1 Staphylococcus genus Decreases
0 1 Blautia genus Decreases
0 1 Bacteroides genus Decreases
0 1 Roseburia genus Decreases
0 1 Parolsenella genus Decreases
0 1 Thomasclavelia genus Decreases
0 1 Bilophila genus Decreases
0 1 Shigella genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Enterocloster genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Clostridium genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 2 Escherichia coli O1:K1:H7 no rank Decreases
0 2 Escherichia coli O139:H1 no rank Decreases
0 2 Escherichia coli O141:H4 no rank Decreases
0 2 Escherichia coli O145:H34 no rank Decreases
0 2 Escherichia coli O15:H12 no rank Decreases
0 2 Escherichia coli O155:H21 no rank Decreases
0 2 Escherichia coli O158:H23 no rank Decreases
0 2 Escherichia coli O16:H48 no rank Decreases
0 2 Escherichia coli O170:H18 no rank Decreases
0 2 Escherichia coli O18ac:H14 no rank Decreases
0 2 Escherichia coli O19:H7 no rank Decreases
0 2 Escherichia coli O2:K1:H4 no rank Decreases
0 2 Escherichia coli O2:K1:H5 no rank Decreases
0 2 Escherichia coli O2:K1:H7 no rank Decreases
0 2 Escherichia coli O20:H12 no rank Decreases
0 2 Escherichia coli O25:H16 no rank Decreases
0 2 Escherichia coli O55:H7 no rank Decreases
0 2 Escherichia coli O68:H12 no rank Decreases
0 2 Escherichia coli O7:H15 no rank Decreases
0 2 Escherichia coli O78:H51 no rank Decreases
0 2 Escherichia coli O80:H26 no rank Decreases
0 2 Escherichia coli O84:H7 no rank Decreases
0 2 Escherichia coli O85:H1 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 2 Escherichia coli O103 serogroup Decreases
0 2 Escherichia coli O111 serogroup Decreases
0 2 Escherichia coli O119 serogroup Decreases
0 2 Escherichia coli O121 serogroup Decreases
0 2 Escherichia coli O145 serogroup Decreases
0 2 Escherichia coli O155 serogroup Decreases
0 2 Escherichia coli O157 serogroup Decreases
0 2 Escherichia coli O177 serogroup Decreases
0 2 Escherichia coli O26 serogroup Decreases
0 2 Escherichia coli O3 serogroup Decreases
0 2 Escherichia coli O43 serogroup Decreases
0 2 Escherichia coli O5 serogroup Decreases
0 2 Escherichia coli O78 serogroup Decreases
0 2 Escherichia coli O86 serogroup Decreases
0 2 Escherichia coli O91 serogroup Decreases
0 2 Escherichia coli H20 serotype Decreases
0 2 Escherichia coli O1:H42 serotype Decreases
0 2 Escherichia coli O1:HNT serotype Decreases
0 2 Escherichia coli O10:H32 serotype Decreases
0 2 Escherichia coli O10:K5(L):H4 serotype Decreases
0 2 Escherichia coli O100:H21 serotype Decreases
0 2 Escherichia coli O103:H11 serotype Decreases
0 2 Escherichia coli O103:H2 serotype Decreases
0 2 Escherichia coli O103:H25 serotype Decreases
0 2 Escherichia coli O104:H21 serotype Decreases
0 2 Escherichia coli O104:H4 serotype Decreases
0 2 Escherichia coli O111:H- serotype Decreases
0 2 Escherichia coli O111:H11 serotype Decreases
0 2 Escherichia coli O111:H8 serotype Decreases
0 2 Escherichia coli O111:NM serotype Decreases
0 2 Escherichia coli O112ab:H8 serotype Decreases
0 2 Escherichia coli O112ac:H19 serotype Decreases
0 2 Escherichia coli O113:H21 serotype Decreases
0 2 Escherichia coli O114:H49 serotype Decreases
0 2 Escherichia coli O118:H16 serotype Decreases
0 2 Escherichia coli O121:H19 serotype Decreases
0 2 Escherichia coli O121:H7 serotype Decreases
0 2 Escherichia coli O123:H11 serotype Decreases
0 2 Escherichia coli O125ac:K+:H10 serotype Decreases
0 2 Escherichia coli O126:H45 serotype Decreases
0 2 Escherichia coli O127:H27 serotype Decreases
0 2 Escherichia coli O127:H6 serotype Decreases
0 2 Escherichia coli O128:H2 serotype Decreases
0 2 Escherichia coli O128ac:H12 serotype Decreases
0 2 Escherichia coli O139:H28 serotype Decreases
0 2 Escherichia coli O145:H25 serotype Decreases
0 2 Escherichia coli O145:H28 serotype Decreases
0 2 Escherichia coli O145:NM serotype Decreases
0 2 Escherichia coli O146:H21 serotype Decreases
0 2 Escherichia coli O15:H18 serotype Decreases
0 2 Escherichia coli O150:H6 serotype Decreases
0 2 Escherichia coli O152:H23 serotype Decreases
0 2 Escherichia coli O153:H2 serotype Decreases
0 2 Escherichia coli O156:H25 serotype Decreases
0 2 Escherichia coli O157:H- serotype Decreases
0 2 Escherichia coli O157:H43 serotype Decreases
0 2 Escherichia coli O157:H7 serotype Decreases
0 2 Escherichia coli O157:NM serotype Decreases
0 2 Escherichia coli O16:H6 serotype Decreases
0 2 Escherichia coli O165:H25 serotype Decreases
0 2 Escherichia coli O167:H26 serotype Decreases
0 2 Escherichia coli O174:H2 serotype Decreases
0 2 Escherichia coli O174:H21 serotype Decreases
0 2 Escherichia coli O174:H8 serotype Decreases
0 2 Escherichia coli O176:H45 serotype Decreases
0 2 Escherichia coli O177:NM serotype Decreases
0 2 Escherichia coli O2:H6 serotype Decreases
0 2 Escherichia coli O2:K2:H1 serotype Decreases
0 2 Escherichia coli O25:H1 serotype Decreases
0 2 Escherichia coli O25:NM serotype Decreases
0 2 Escherichia coli O26:H1 serotype Decreases
0 2 Escherichia coli O26:H11 serotype Decreases
0 2 Escherichia coli O28ac:NM serotype Decreases
0 2 Escherichia coli O29:H4 serotype Decreases
0 2 Escherichia coli O32:H37 serotype Decreases
0 2 Escherichia coli O39:NM serotype Decreases
0 2 Escherichia coli O44:H18 serotype Decreases
0 2 Escherichia coli O45:H2 serotype Decreases
0 2 Escherichia coli O6:H16 serotype Decreases
0 2 Escherichia coli O6:H16:CFA/II serotype Decreases
0 2 Escherichia coli O6:K2:H1 serotype Decreases
0 2 Escherichia coli O69:H11 serotype Decreases
0 2 Escherichia coli O7:H4 serotype Decreases
0 2 Escherichia coli O7:K1 serotype Decreases
0 2 Escherichia coli O78:H12 serotype Decreases
0 2 Escherichia coli O78:H4 serotype Decreases
0 2 Escherichia coli O79:H7 serotype Decreases
0 2 Escherichia coli O8:H8 serotype Decreases
0 2 Escherichia coli O81:NM serotype Decreases
0 2 Escherichia coli O83:H1 serotype Decreases
0 2 Escherichia coli O86:H34 serotype Decreases
0 2 Escherichia coli O89m:H10 serotype Decreases
0 2 Escherichia coli O89m:H9 serotype Decreases
0 2 Escherichia coli O9:H10 serotype Decreases
0 2 Escherichia coli O91:H14 serotype Decreases
0 2 Escherichia coli O91:NM serotype Decreases
0 2 Escherichia coli O99:H6 serotype Decreases
0 2 Escherichia coli ONT:H33 serotype Decreases
2 0 Escherichia coli species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Bacteroides ovatus species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Eggerthella lenta species Decreases
1 0 Veillonella parvula species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Segatella copri species Decreases
1 0 Candida albicans species Decreases
1 0 Pseudomonas aeruginosa species Decreases
1 0 Staphylococcus aureus species Decreases
1 0 Blautia obeum species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Roseburia hominis species Decreases
0 1 Veillonella rodentium species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
0 1 Bacteroides luhongzhouii species Decreases
1 0 Thomasclavelia ramosa species Decreases
0 1 Veillonella dispar species Decreases
0 1 Eggerthella guodeyinii species Decreases
1 0 Bilophila wadsworthia species Decreases
0 1 Segatella bryantii species Decreases
0 1 Bifidobacterium breve species Decreases
0 1 Veillonella sp. S12025-13 species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Veillonella nakazawae species Decreases
1 0 Ruminococcus bromii species Decreases
0 1 Parolsenella catena species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Veillonella rogosae species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Bacteroides sp. M10 species Decreases
0 1 Coprococcus catus species Decreases
0 1 Shigella dysenteriae species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Dorea longicatena species Decreases
1 0 Enterocloster bolteae species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Coprobacter secundus species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
0 1 Barnesiella viscericola species Decreases
0 1 Leyella stercorea species Decreases
0 1 Coprococcus comes species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Veillonella atypica species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Olsenella sp. oral taxon 807 species Decreases
0 1 Bacillus paralicheniformis species Decreases
0 1 Coprobacter fastidiosus species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Bifidobacterium catenulatum species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Prevotella intermedia species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Ruminococcus gauvreauii species Decreases
0 1 Actinomyces oris species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Parafannyhessea umbonata species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Blautia liquoris species Decreases
0 1 Bacteroides caecimuris species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Christensenella minuta species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Butyricimonas faecalis species Decreases
0 1 Shigella boydii species Decreases
0 1 Leyella lascolaii species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Parvimonas micra species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Bifidobacterium bifidum species Decreases
0 1 Roseburia intestinalis species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 Corynebacterium durum species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 Faecalibacterium sp. I3-3-33 species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Phoenicibacter congonensis species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Parabacteroides merdae species Decreases
0 1 Faecalibacterium sp. IP-1-18 species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Faecalibacterium sp. I4-3-84 species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Oscillibacter hominis species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Actinomyces sp. oral taxon 171 species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Bacteroides intestinalis species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Paraprevotella clara species Decreases
0 1 Prevotella bivia species Decreases
0 1 Eubacterium limosum species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
1 0 Bacteroides caccae species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Eubacterium callanderi species Decreases
0 1 Blautia wexlerae species Decreases
0 1 Eubacterium sp. c-25 species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 [Eubacterium] hominis species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Alistipes dispar species Decreases
0 1 Paraprevotella xylaniphila species Decreases
0 1 Alistipes senegalensis species Decreases
0 1 Treponema peruense species Decreases
0 1 Alistipes shahii species Decreases
0 1 Olsenella uli species Decreases
0 1 Actinomyces sp. oral taxon 169 species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Intestinimonas butyriciproducens species Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Pseudomonas aeruginosa group species group Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of fluvoxamine maleate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.4 0.4
Acne 0.5 0.4 0.25
ADHD 3.7 0.7 4.29
Age-Related Macular Degeneration and Glaucoma 0.7 0.7
Allergic Rhinitis (Hay Fever) 2.7 2.8 -0.04
Allergies 7.4 3.7 1
Allergy to milk products 1.9 0.9 1.11
Alopecia (Hair Loss) 0.9 0.1 8
Alzheimer's disease 5.3 4.9 0.08
Amyotrophic lateral sclerosis (ALS) Motor Neuron 3.2 1 2.2
Ankylosing spondylitis 4.5 0.6 6.5
Anorexia Nervosa 0.7 1.7 -1.43
Antiphospholipid syndrome (APS) 1 0.1 9
Asthma 5.8 3.4 0.71
Atherosclerosis 2.6 1.4 0.86
Atrial fibrillation 2.8 2.2 0.27
Autism 7.8 7.5 0.04
Autoimmune Disease 0.6 0.6 0
Barrett esophagus cancer 0.5 0.5
benign prostatic hyperplasia 0.5 0.2 1.5
Biofilm 2.7 2.7
Bipolar Disorder 1.1 1.2 -0.09
Brain Trauma 1.3 1.1 0.18
Breast Cancer 0.3 0.3
Cancer (General) 0.8 2.4 -2
Carcinoma 2.6 1.9 0.37
Celiac Disease 2.8 3.5 -0.25
Cerebral Palsy 2 0.7 1.86
Chronic Fatigue Syndrome 3.8 5 -0.32
Chronic Kidney Disease 3.3 2.7 0.22
Chronic Lyme 0.6 0.4 0.5
Chronic Obstructive Pulmonary Disease (COPD) 2.3 1 1.3
Chronic Urticaria (Hives) 1 1.2 -0.2
Coagulation / Micro clot triggering bacteria 1.6 0.5 2.2
Cognitive Function 1.3 0.9 0.44
Colorectal Cancer 3.3 1.9 0.74
Constipation 0.9 0.4 1.25
Coronary artery disease 1.8 2.4 -0.33
COVID-19 10.5 10.8 -0.03
Crohn's Disease 5.2 4.9 0.06
Cushing's Syndrome (hypercortisolism) 0.5 0.2 1.5
cystic fibrosis 1.8 1.6 0.13
d-lactic acidosis (one form of brain fog) 0.8 0.8
deep vein thrombosis 2.1 0.5 3.2
Denture Wearers Oral Shifts 1.9 1.9
Depression 7.2 7.7 -0.07
Dermatomyositis 0.5 0.4 0.25
Eczema 1.6 1 0.6
Endometriosis 2.6 1.7 0.53
Eosinophilic Esophagitis 0.5 -0.5
Epilepsy 2.5 2 0.25
erectile dysfunction 0.5 0.4 0.25
Fibromyalgia 2.5 1.3 0.92
Functional constipation / chronic idiopathic constipation 3.8 2.3 0.65
gallstone disease (gsd) 2.2 1 1.2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.5 1.4 -1.8
Generalized anxiety disorder 1.9 1.7 0.12
giant cell arteritis 0 0
Gout 2 0.6 2.33
Graves' disease 1.5 2.3 -0.53
Gulf War Syndrome 0.3 1.7 -4.67
Halitosis 0.7 0.7
Hashimoto's thyroiditis 2.9 1.8 0.61
Heart Failure 3.2 2.2 0.45
hemorrhagic stroke 0.3 0.3
Hidradenitis Suppurativa 1.9 0.5 2.8
High Histamine/low DAO 0.8 0.5 0.6
hypercholesterolemia (High Cholesterol) 0.7 0.6 0.17
hyperglycemia 1.8 1.9 -0.06
Hyperlipidemia (High Blood Fats) 1.3 0.3 3.33
hypersomnia 0.7 -0.7
hypertension (High Blood Pressure 3.9 4.8 -0.23
Hypothyroidism 1.6 1 0.6
Hypoxia 1.4 1.4
IgA nephropathy (IgAN) 1.2 4 -2.33
Inflammatory Bowel Disease 6.3 8.7 -0.38
Insomnia 2.6 3.5 -0.35
Intelligence 0.8 0.6 0.33
Intracranial aneurysms 0.7 0.3 1.33
Irritable Bowel Syndrome 6.6 3.8 0.74
ischemic stroke 2.8 1 1.8
Juvenile idiopathic arthritis 0.5 0.5
Liver Cirrhosis 5.8 3.7 0.57
Long COVID 5 7 -0.4
Low bone mineral density 0.8 -0.8
Lung Cancer 0.5 1.4 -1.8
Lymphoma 0.3 0.3
Mast Cell Issues / mastitis 1.5 0.5 2
ME/CFS with IBS 0.2 2.3 -10.5
ME/CFS without IBS 1.2 1.7 -0.42
Menopause 2.3 0.6 2.83
Metabolic Syndrome 5.3 5.7 -0.08
Mood Disorders 7.4 6.7 0.1
multiple chemical sensitivity [MCS] 0.9 0.2 3.5
Multiple Sclerosis 5.8 3.9 0.49
Multiple system atrophy (MSA) 1.4 0.7 1
myasthenia gravis 0.3 0.2 0.5
neuropathic pain 0.4 2.3 -4.75
Neuropathy (all types) 1.1 1 0.1
neuropsychiatric disorders (PANDAS, PANS) 0.7 0.7
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 4.3 5.3 -0.23
NonCeliac Gluten Sensitivity 2.1 0.6 2.5
Obesity 9.4 5.8 0.62
obsessive-compulsive disorder 4 3.4 0.18
Osteoarthritis 1.7 1.3 0.31
Osteoporosis 2.2 1.6 0.38
pancreatic cancer 0.6 0.6
Parkinson's Disease 7.4 5 0.48
Polycystic ovary syndrome 2.2 2.2 0
Postural orthostatic tachycardia syndrome 0 0.4 0
Premenstrual dysphoric disorder 1.2 1.2
primary biliary cholangitis 0.8 0.4 1
Primary sclerosing cholangitis 1.5 1.1 0.36
Psoriasis 4.1 2.2 0.86
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 7.4 3.1 1.39
Rosacea 1.1 0.2 4.5
Schizophrenia 6.3 2.3 1.74
scoliosis 1 0.8 0.25
sensorineural hearing loss 1.2 1.2
Sjögren syndrome 2.7 2 0.35
Sleep Apnea 1.6 1 0.6
Slow gastric motility / Gastroparesis 1.1 0.4 1.75
Small Intestinal Bacterial Overgrowth (SIBO) 1.8 0.6 2
Stress / posttraumatic stress disorder 2.3 2.3 0
Systemic Lupus Erythematosus 3.2 1.6 1
Tic Disorder 0.4 2 -4
Tourette syndrome 0.8 0.2 3
Type 1 Diabetes 3.7 3 0.23
Type 2 Diabetes 5.7 4.6 0.24
Ulcerative colitis 3.1 5.2 -0.68
Unhealthy Ageing 2.7 2.1 0.29
Vitiligo 1 1.2 -0.2

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]